Vaccine firm will get $400,000 from Indiana Seed Fund

Bioscience Vaccines will receive an investment of $400,000 from the Indiana Seed Fund, which was set up by BioCrossroads to help life sciences firms. Bioscience plans to put the money toward a technology that can be used to develop adjuvants, which can boost the efficacy of vaccines.

View Full Article in:

Indianapolis Star (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC